Pediatrix reported second-quarter earnings of $0.49 per share
Net revenue rose 4% to $488 million, Adjusted EBITDA $76 million, and the company reaffirmed its 2026 outlook.
See the latest news and media coverage for Pediatrix. We track all announcements, press releases, and industry mentions in real time, all in one place.
Provider of prenatal, neonatal and pediatric services
pediatrix.comLast updated
In short: Pediatrix reported Q2 revenue growth to $488 million and reaffirmed its 2026 adjusted EBITDA outlook of $280 million to $300 million.
Net revenue rose 4% to $488 million, Adjusted EBITDA $76 million, and the company reaffirmed its 2026 outlook.
Net revenue was $476 million and adjusted EBITDA was $58 million. The company reaffirmed its 2026 outlook.
Net revenue of $493 million, net income of $72 million, and adjusted EBITDA of $87 million for the quarter. Adjusted EBITDA outlook raised to $270-$290 million.
The call at 9:00 a.m. ET on November 3 will discuss results for the quarter ended September 30, 2025.
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Detailed price information for Pediatrix Medical Group Inc (MD-N) from The Globe and Mail including charting and trades.
Pediatrix Medical Group Q2 results: non-GAAP EPS $0.63 beats, revenue $488M up 4.1%.
Pediatrix Medical on Tuesday reported adjusted earnings of $0.63 per share for the second quarter, versus $0.53 a year earlier. The...
Track Pediatrix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.